The U.S Federal Aviation Administration said on Wednesday it was delaying requirements for air traffic controllers to get at ...

Shares of Tracon Pharmaceuticals (NASDAQ:TCON) dropped sharply on Wednesday after early data from the company’s pivotal ...

TRACON Pharmaceuticals, Inc. engages in the development and commercialization of targeted therapies for cancer, and ophthalmic and fibrotic diseases. Its products include TRC105, an anti-endoglin ...

TRACON Pharmaceuticals (TCON – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Edward White from H.C. Wainwright reiterated a Buy rating on ...

TRACON Pharmaceuticals Inc has a consensus price target of $4.4, established from looking at the 10 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC ...

All the Latest Game Footage and Images from Tracon!2012:SE - Atlanta Sector Atlanta (KATL) sector is a sector DLC for Tracon!2012:SE Advertisement All the Latest Game Footage and Images from Tracon!

SAN DIEGO - TRACON Pharmaceuticals (NASDAQ: NASDAQ:TCON), a clinical-stage biopharmaceutical company, has approved a reverse stock split of its common stock at a ratio of one-for-twenty, set to take ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

All the Latest Game Footage and Images from Tracon!2012:SE - Frankfurt Sector Jump to: Tech | Gaming | Home | Lifestyle | Media Frankfurt (EDDF) sector is and sector DLC for Tracon!2012 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Here's a look at some of Charles Schwab's top performing mutual funds, each of which possesses a four- or five-star Morningstar rating. Airline travel numbers are above pre-pandemic levels and ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...